|
CDC5L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.194700E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.540300E-02 |
| Normal-vs-Stage2 |
1.117220E-01 |
| Normal-vs-Stage3 |
7.92600000000254E-05 |
| Normal-vs-Stage4 |
5.77619999999612E-05 |
| Stage1-vs-Stage2 |
6.297200E-01 |
| Stage1-vs-Stage3 |
5.963800E-03 |
| Stage1-vs-Stage4 |
3.555300E-03 |
| Stage2-vs-Stage3 |
1.793820E-01 |
| Stage2-vs-Stage4 |
1.382240E-01 |
| Stage3-vs-Stage4 |
9.001800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.807400E-04 |
| Normal-vs-AfricanAmerican |
5.242400E-02 |
| Normal-vs-Asian |
1.884170E-01 |
| Caucasian-vs-AfricanAmerican |
8.083600E-01 |
| Caucasian-vs-Asian |
9.787200E-01 |
| AfricanAmerican-vs-Asian |
9.466000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.564220E-04 |
| Normal-vs-Female |
1.432340E-02 |
| Male-vs-Female |
1.964640E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.400200E-02 |
| Normal-vs-Age(41-60Yrs) |
9.840100E-03 |
| Normal-vs-Age(61-80Yrs) |
5.430200E-04 |
| Normal-vs-Age(81-100Yrs) |
2.235300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.576400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.993600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.990200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.246400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.507800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.595900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.695820E-02 |
| Normal-vs-Grade 2 |
9.948100E-02 |
| Normal-vs-Grade 3 |
2.27239999999185E-05 |
| Normal-vs-Grade 4 |
1.71810000004768E-06 |
| Grade 1-vs-Grade 2 |
1.000110E-02 |
| Grade 1-vs-Grade 3 |
7.372200E-04 |
| Grade 1-vs-Grade 4 |
6.20829999999906E-05 |
| Grade 2-vs-Grade 3 |
2.037000E-03 |
| Grade 2-vs-Grade 4 |
1.207760E-04 |
| Grade 3-vs-Grade 4 |
1.523420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.342000E-01 |
| Normal-vs-ccB subtype |
9.647500E-04 |
| ccA subtype-vs-ccB subtype |
8.736100E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.296430E-02 |
| Normal-vs-N1 |
2.802400E-02 |
| N0-vs-N1 |
1.642180E-01 |
|
|
